Lotus Pharmaceutical Co., Ltd. (1795.TW)
Taiwan - Taiwan Delayed price. Currency in TWD
Add to watchlist
At close: 01:30PM CST
| Previous close | 289.00 |
| Open | 290.00 |
| Bid | 290.00 x N/A |
| Ask | 290.50 x N/A |
| Day's range | 289.50 - 296.50 |
| 52-week range | 205.00 - 347.00 |
| Volume | |
| Avg. volume | 6,241,709 |
| Market cap | 76.696B |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | 19.27 |
| EPS (TTM) | 15.05 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | 3.46 (1.19%) |
| Ex-dividend date | 05 Jul 2023 |
| 1y target est | 438.33 |
- Business Wire
Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY® in Multiple Markets Across Asia
BOSTON & TAIPEI, Taiwan, August 10, 2023--Corium, LLC ("Corium"), a commercial-stage biopharmaceutical company leading the development and commercialization of novel neuroscience therapies, and Lotus Pharmaceutical (1795:TT; "Lotus"), a multinational pharmaceutical company, announced that the companies have entered into an exclusive Collaboration and License Agreement for ADLARITY® (donepezil transdermal system), an innovative Alzheimer’s dementia treatment, in ten markets across Asia.
© 2024 Yahoo. All rights reserved.